World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
30949
World Ranking
14004
National Ranking
1295

Overview

Darius F. Mirza is affiliated with the University of Birmingham in the United Kingdom. Their research primarily focuses on medicine, with an emphasis on surgery and hepatology. The work spans several interconnected subfields such as oncology, pulmonary and respiratory medicine, and epidemiology.

The scientist's publications emphasize liver disease and transplantation, as well as oncological aspects related to the liver and pancreas. Their main areas of study include:

  • Liver Disease and Transplantation
  • Organ Transplantation Techniques and Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease Diagnosis and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Organ Donation and Transplantation

Frequent coauthors collaborating with Darius F. Mirza include:

  • Keith Roberts
  • Ravi Marudanayagam
  • John Isaac
  • B. Dasari
  • N. Chatzizacharias

Their research is regularly published in specialized journals, with notable contributions in:

  • HPB
  • British Journal of Surgery
  • Transplantation
  • Pediatric Transplantation
  • Liver Transplantation

Among the recent papers featuring their work are:

  • "Transplantation of discarded livers following viability testing with normothermic machine perfusion," 2020, Nature Communications
  • "Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines," 2021, The Lancet. Gastroenterology & hepatology
  • "mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors," 2020, Annals of Surgery
  • "Clinical Spectrum of Children with Acute Hepatitis of Unknown Cause," 2022, New England Journal of Medicine
  • "Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry," 2021, Annals of Surgical Oncology

Best Publications

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Bengt Glimelius;Graeme J Poston

  • Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983) : long-term results of a randomised, controlled, phase 3 trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

  • A randomized trial of normothermic preservation in liver transplantation

    David Nasralla;Constantin C Coussios;Hynek Mergental;M Zeeshan Akhtar

  • Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

    John N Primrose;Richard P Fox;Daniel H Palmer;Hassan Z Malik

  • Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)

    René Adam;Vincent Karam;Valérie Delvart;John O'Grady

  • Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome.

    M A Yerdel;B Gunson;D Mirza;K Karayalçin

  • Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis

    Michael A Silva;Bassem Hegab;Christopher J Hyde;Boliang Guo

  • Guidelines for resection of colorectal cancer liver metastases

    O J Garden;M Rees;G J Poston;D Mirza

  • Liver Transplantation After Ex Vivo Normothermic Machine Preservation: A Phase 1 (First-in-Man) Clinical Trial

    R. Ravikumar;W. Jassem;H. Mergental;N. Heaton

  • Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

    Edward K. Geissler;Andreas A. Schnitzbauer;Andreas A. Schnitzbauer;Carl Zülke;Philipp E. Lamby

  • 2018 annual report of the European Liver Transplant Registry (ELTR) – 50‐year evolution of liver transplantation

    René Adam;Vincent Karam;Valérie Cailliez;John G. O Grady

  • Hepatic artery thrombosis following orthotopic liver transplantation: A 10‐year experience from a single centre in the United Kingdom

    Michael A. Silva;Periyathambi S. Jambulingam;Bridget K. Gunson;David Mayer

  • Transplantation of discarded livers following viability testing with normothermic machine perfusion

    Hynek Mergental;Hynek Mergental;Richard W. Laing;Richard W. Laing;Amanda J. Kirkham;M. Thamara P. R. Perera

  • Transplantation of Declined Liver Allografts Following Normothermic Ex-Situ Evaluation

    H. Mergental;H. Mergental;M. T. P. R. Perera;R. W. Laing;P. Muiesan

  • Liver transplantation for acute liver failure in Europe: Outcomes over 20 years from the ELTR database

    Giacomo Germani;Eleni Theocharidou;Renè Adam;Vincent Karam

  • A re‐evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts

    Edward Alabraba;Edward Alabraba;Peter Nightingale;Bridget Gunson;Bridget Gunson;Stefan Hubscher;Stefan Hubscher

  • Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation.

    J. Peter A. Lodge;Sven Jonas;Robert M. Jones;Michael Olausson

  • Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients

    Luca Viganò;Lorenzo Capussotti;Réal Lapointe;Eduardo Barroso

  • Liver resection for colorectal metastases.

    S R Bramhall;U Gur;C Coldham;B K Gunson

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983)

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

Frequent Co-Authors

René Adam
René Adam University of Paris-Saclay
Stephen J. Wigmore
Stephen J. Wigmore University of Edinburgh
Stefan G. Hubscher
Stefan G. Hubscher University of Birmingham
Wolf O. Bechstein
Wolf O. Bechstein Goethe University Frankfurt
Deirdre A. Kelly
Deirdre A. Kelly University of Birmingham
Peter J. Friend
Peter J. Friend University of Oxford
James Neuberger
James Neuberger Queen Elizabeth Hospital Birmingham
Philip N. Newsome
Philip N. Newsome University of Birmingham
Andrew K. Burroughs
Andrew K. Burroughs University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in medical careers but want alternative or flexible pathways, there are several online degree options to consider. Accelerated nursing programs are increasingly popular for those drawn to patient care. You can find absn programs that don’t require teas, offering a faster track to becoming a nurse without additional standardized test hurdles.

For those interested in administrative roles and hospital leadership, a health care administration degree online can open doors in management, public health, or business-side healthcare positions. Nurses looking to advance further can opt for rn to np bridge programs that offer streamlined paths from ADN to a master’s degree, preparing graduates for advanced practice and greater career flexibility.

Another expanding field is nutrition. With online degrees in nutrition, students can prepare for careers as nutritionists, dietitians, or wellness consultants—all with the flexibility of remote learning. Exploring these online programs can help you find the right fit for your healthcare career goals, even outside traditional medical school.

Best Scientists Citing Darius F. Mirza

Trending Scientists